Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
VolitionRX (VNRX)
NYSE MKT:VNRX
VolitionRX (VNRX) Stock Price & Analysis
435 Followers
VNRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $1.55
Previous Close$0.66
Volume64.10K
Average Volume (3M)179.80K
Market Cap
$54.64M
Enterprise Value$47.49M
Total Cash (Recent Filing)$11.77M
Total Debt (Recent Filing)$5.55M
Price to Earnings (P/E)―
Beta1.33
Next Earnings
Aug 12, 2024EPS Estimate
-$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding82,815,121
10 Day Avg. Volume74,215
30 Day Avg. Volume179,800
Standard Deviation0.19
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-3.40
Price to Sales (P/S)220.64
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue67.57
Enterprise Value/Gross Profit61.26
Enterprise Value/Ebitda-1.37
Forecast
1Y Price Target
$2.50Price Target Upside278.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
VolitionRX News
PremiumCompany Announcements
VolitionRX Stockholders Set Course with Key Governance Decisions
PremiumCompany Announcements
VolitionRX Mid-Year Review Update Now Available
PremiumPre-Earnings
Is VNRX a Buy, Before Earnings?
PremiumCompany Announcements
VolitionRX Announces Board Reshuffle and Bylaws Amendment
Ownership Overview
28.98% Insiders
1.62% Mutual Funds
0.97% Other Institutional Investors
68.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VNRX FAQ
What was VolitionRX’s price range in the past 12 months?
VolitionRX lowest stock price was $0.55 and its highest was $1.55 in the past 12 months.
What is VolitionRX’s market cap?
Currently, no data Available
When is VolitionRX’s upcoming earnings report date?
VolitionRX’s upcoming earnings report date is Aug 12, 2024 which is in 20 days.
How were VolitionRX’s earnings last quarter?
VolitionRX released its earnings results on May 13, 2024. The company reported -$0.1 earnings per share for the quarter, the consensus estimate of -$0.1 by $0.
Is VolitionRX overvalued?
According to Wall Street analysts VolitionRX’s price is currently Undervalued.
Does VolitionRX pay dividends?
VolitionRX does not currently pay dividends.
What is VolitionRX’s EPS estimate?
VolitionRX’s EPS estimate is -$0.09.
How many shares outstanding does VolitionRX have?
VolitionRX has 82,928,314 shares outstanding.
What happened to VolitionRX’s price movement after its last earnings report?
VolitionRX reported an EPS of -$0.1 in its last earnings report, expectations of -$0.1. Following the earnings report the stock price went down -14.773%.
Which hedge fund is a major shareholder of VolitionRX?
Currently, no hedge funds are holding shares in VNRX
---
VolitionRX Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.50 (278.79% Upside)
$2.50 (278.79% Upside)
Blogger Sentiment
Bullish
VNRX Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.9%
Last 30 Days ▲ 3.1%
Last 30 Days ▲ 3.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
7.71%
Trailing 12-Months
Company Description
VolitionRX
VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Austin, TX.
---
VNRX Earnings Call
Q1 2024
0:00 / 0:00
---
VNRX Stock 12 Month Forecast
Average Price Target
$2.50
▲(278.79% Upside)
Technical Analysis
Best Analysts Covering VNRX
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-31.76%
reiterated a buy rating 2 months ago
Copying Ross Osborn's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -31.76% per trade.
---